Ken Valenzano, VP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), bought 7,000 shares at $5.40 ($38K) on 2014-08-20, disclosed to the SEC on 2014-08-21.
Scheduled purchase ($38k) by VP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2015-05-12 | $141K | — | Filing → |
| FOLD | SELL | 2015-04-17 | $63K | — | Filing → |
| FOLD | SELL | 2015-03-25 | $91K | — | Filing → |